Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy - Wikidata - wikimedia - TriplyDB

Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy

Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy

http://www.wikidata.org/entity/Q35127584

about

Multiple functions of sushi domain containing 2 (SUSD2) in breast tumorigenesis Galectin-1 research in T cell immunity: past, present and future Von Willebrand factor, angiodysplasia and angiogenesis Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment Galectins in epithelial functions Galectin-1 Prevents Infection and Damage Induced by Trypanosoma cruzi on Cardiac Cells Identification of galectin-1 as a critical factor in function of mouse mesenchymal stromal cell-mediated tumor promotion Structural Basis for Galectin-1-dependent Pre-B Cell Receptor (Pre-BCR) Activation The Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1 Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia Blocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growth Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection Ras inhibition boosts galectin-7 at the expense of galectin-1 to sensitize cells to apoptosis Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma Proteomic analyses of the Xiphophorus Gordon-Kosswig melanoma model.VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis.Galectins and gliomas.Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future.Galectin-1 expression imprints a neurovascular phenotype in proliferative retinopathies and delineates responses to anti-VEGF Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer.Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1.Galectin-1 links tumor hypoxia and radiotherapy.Galectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer.Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion.Role of galectins in re-epithelialization of wounds.Glycobiology of ocular angiogenesis.Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response.Folding and function in α/β-peptides: targets and therapeutic applications.Proteomic comparison of mcf-7 tumoursphere and monolayer cultures Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding Enhancement of T-cell-mediated antitumor response: angiostatic adjuvant to immunotherapy against cancer.Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven The anti-angiogenic peptide anginex greatly enhances galectin-1 binding affinity for glycoproteins.Fingerprinting of galectins in normal, P. aeruginosa-infected, and chemically burned mouse corneas Timing of galectin-1 exposure differentially modulates Nipah virus entry and syncytium formation in endothelial cells.Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma.Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress.

P2860

Q24302420-FF9A08C9-207B-4467-9425-ED1AB73F6AA4 Q26825120-F64D1CEA-6470-4C14-B841-D7850E575E05 Q26852889-7F2812A4-1688-4F6F-A24D-6E5FB99C2836 Q26991865-5C05DA06-432F-4830-8F76-A452CF087B56 Q27000800-B513191F-7646-45A8-BEF4-B9337D70CD95 Q27303934-0FE4BB83-E56F-46AD-A0EF-0CE5991C8856 Q27332209-636779B9-853A-4C84-9AEA-AC8E385D663D Q27674972-EEC22F4E-622E-48AF-AFBC-7A2344CD2A68 Q28075523-47960CB9-1E22-4ABE-8AC8-8CAED9E5A2F6 Q28081459-BC825232-1330-45C0-A10A-ED884E3A7B25 Q28116133-E08696DE-7C42-4B3D-8B23-A7D703852500 Q28252518-91157BBE-F2A7-41A5-A403-DBFF5A0A39FF Q28287799-77730F6A-30F4-4505-BE3F-1ABC75CC6ABB Q28742668-6FA56651-26B9-4EB3-BEEA-A504C765F168 Q30423099-1AC53789-6D8E-4A55-868C-6F57849472EE Q31121321-A38EA267-5AC4-45E3-9440-7AE7FBA5511E Q33588438-B46751AA-71BC-4B83-9F39-9FA92B4769F2 Q33692511-ADF10210-37F3-4119-818B-50DE76773F61 Q33705268-7F98CED9-7279-4370-A809-0C8C1E11F043 Q33779141-87BE6B8C-7181-4AC1-B5EE-6B053FFB2930 Q33814898-9735A308-7890-4642-A7F0-758930BF0482 Q34039409-A7F0261B-2309-4E99-8A7A-BEE622A50C08 Q34060270-72938893-A5BA-44C9-B1FA-2645CFA4D13B Q34129297-D1B6503D-2FC7-4809-AA3D-1170FF872248 Q34258192-C3009C6B-1B8B-4978-A9AB-B9810D7286B9 Q34268364-651A9AC2-37F9-4BEB-BABF-7AF9F47EEBC1 Q34385160-344DE902-DF39-47F5-8CC7-18F455833D06 Q34414227-EEE613CC-AD93-4D3A-9FB4-17538E600A74 Q34438522-453B2E02-0A61-4000-AC61-CFE5FD3EFD5B Q34483276-1E4F07E9-F17F-45DF-A5C3-10837F2AE152 Q34534423-0A141118-45E1-49F6-AFF9-62830FDA8F2D Q34564173-B83A74B0-1B12-4A49-A90A-8D749849B845 Q34564433-3A923F29-F98F-4451-9633-5F0CAF6BF41D Q34589227-4235D11B-153F-464D-BB0A-ED99D15F4B93 Q34799812-99BBD752-8B65-4F83-A24B-7DDD389C046F Q34999835-EBD6BCBB-E2A1-40C1-90A0-955B99278BD8 Q35076790-6F253015-2596-4BB9-B57D-6BDEEB340C18 Q35085674-C21C90EF-83C8-42FC-BAB3-ADA5DB47D9A4 Q35111396-04EF19B4-8138-4560-9F25-6B63FA52C821 Q35161285-2F4A9DBD-38E0-4193-87ED-AD7FCBD7C191

P2860

Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy

http://www.wikidata.org/entity/Q35127584

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Galectin-1 is essential in tum ...... t for antiangiogenesis therapy

@ast

Galectin-1 is essential in tum ...... t for antiangiogenesis therapy

@en

type

label

Galectin-1 is essential in tum ...... t for antiangiogenesis therapy

@ast

Galectin-1 is essential in tum ...... t for antiangiogenesis therapy

@en

prefLabel

Galectin-1 is essential in tum ...... t for antiangiogenesis therapy

@ast

Galectin-1 is essential in tum ...... t for antiangiogenesis therapy

@en

P1433

Q35127584-1154D612-C277-4010-9DF0-FB93CA65278C

P1476

Q35127584-84DD6BA0-C82C-4F20-A9C5-A050F06EE11B

P2093

Q35127584-16B4A4D4-69AC-463C-9AE0-F1260E4FF0C5

Q35127584-40697DAC-5626-47BC-87C8-F34A32406E8A

Q35127584-467779D2-34DF-4CF9-8112-87B5EA10CB19

Q35127584-6711DCE0-AF77-49A8-BA9F-DBD7B63E6E90

Q35127584-B8CB9B3A-3EEC-4E09-B68F-E991F77E3726

Q35127584-BD7F3ECB-691E-4E40-98EE-7F85EFEED56B

Q35127584-D7A0893E-1768-4E6F-A630-084722DB4409

Q35127584-F9C4E630-360C-454F-87F1-6606D711FE31

P2860

Q35127584-114BD811-96A7-4D94-8527-DECBB14D8FA9

Q35127584-1B4087FC-69D4-4535-9782-77EEB9C03918

Q35127584-1BC24FDA-D863-4025-BDB8-CB21C99FFEA9

Q35127584-1D04A42E-1E62-4002-9367-4DFB931C8B45

Q35127584-25DDFDC5-8E25-4ADB-99BF-B5273F2D1FED

Q35127584-31E01EDA-8217-4A57-BDB7-C307E7230DCA

Q35127584-35E1BC02-4E3C-48CB-884A-D5E9AEA1BD9E

Q35127584-3A651472-DD37-4097-8BBE-1821E2A5E49A

Q35127584-3C83F58D-DB87-44E7-AD15-7382E5C94C2B

Q35127584-42C86DBA-7FCD-4066-8B50-E0F0CB757F19

P304

Q35127584-1DB6F0F1-A450-4A79-8AAD-3C86D63CC5E0

P31

Q35127584-383B378C-C443-4A91-BA4A-2FBFF5D3E577

P356

Q35127584-B8208A3E-8F95-4B6E-9E3F-EF5023F5B4BE

P407

Q35127584-39CFDFDC-859B-4C77-8A2F-8B2AF753DD33

P433

Q35127584-68354E1A-0F26-439E-A25E-C8947329294C

P478

Q35127584-7908AEAF-7303-458C-AE81-39A00B8A5C08

P50

Q35127584-29109144-E9C4-40E3-B223-21A0E676C40B

Q35127584-45EEA6F0-A3F1-42A5-8A49-F31350AA5B53

Q35127584-627F1DAF-AF36-44EB-9367-ADBF6BC60175

Q35127584-E0647C6E-FA2A-4E5C-9339-50C2CFBBFA40

Q35127584-E5508DE6-F921-4634-BA8E-7DBE88BE49CD

P577

Q35127584-74697303-20C3-4073-A40D-B5AB0FB6E535

P5875

Q35127584-3FE4089C-A079-44BC-879A-46DCB68FAC75

P698

Q35127584-DC063647-6ECC-4C70-BE2A-5E723AFEE421

P932

Q35127584-B138E820-6D77-496F-840F-4A3C3CA9B9ED

P356

PNAS.0603883103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Galectin-1 is essential in tum ...... t for antiangiogenesis therapy

@en

P2093

Arjan W Griffioen

http://www.w3.org/2001/XMLSchema#string

Françoise Poirier

http://www.w3.org/2001/XMLSchema#string

Kevin H Mayo

http://www.w3.org/2001/XMLSchema#string

Linda G Baum

http://www.w3.org/2001/XMLSchema#string

Nicole Verhofstad

http://www.w3.org/2001/XMLSchema#string

Ricardo J M G E Brandwijk

http://www.w3.org/2001/XMLSchema#string

Ruben Postel

http://www.w3.org/2001/XMLSchema#string

Sietske Satijn

http://www.w3.org/2001/XMLSchema#string

P2860

Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein

Mutations affecting morphogenesis during gastrulation and tail formation in the zebrafish, Danio rerio

In vivo imaging of embryonic vascular development using transgenic zebrafish

Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion.

Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature

Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.

Galectinomics: finding themes in complexity.

Galectins as modulators of cell adhesion.

Galectins as modulators of tumour progression.

A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis.

P304

15975-15980

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0603883103

http://www.w3.org/2001/XMLSchema#string

P407

P433

43

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Victor L Thijssen

Irina Nesmelova

Yusaku Nakabeppu

P577

2006-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6752836

http://www.w3.org/2001/XMLSchema#string

P698

17043243

http://www.w3.org/2001/XMLSchema#string

P932

1635112

http://www.w3.org/2001/XMLSchema#string